These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31696470)

  • 1. MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells.
    Du SL; Xu LY; Gao P; Liu QS; Lu FF; Mo ZH; Fan ZZ; Cheng XL; Dong ZH
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8833-8840. PubMed ID: 31696470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY; Cui JH; Liang S; Li HL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL; Wang HB; Yong JK; Zhong J; Li QH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
    Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
    Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance.
    Wang C; Wang C; Qiu C; Su Z
    Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-122 regulates cell apoptosis and ROS by targeting DJ-1 in renal ischemic reperfusion injury rat models.
    Qu XH; Zhang K
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8830-8838. PubMed ID: 30575925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a.
    Li X; Liu K; Zhou W; Jiang Z
    Cancer Biomark; 2020; 27(1):105-111. PubMed ID: 31771044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.
    Feng C; Ma F; Hu C; Ma JA; Wang J; Zhang Y; Wu F; Hou T; Jiang S; Wang Y; Feng Y
    Cell Cycle; 2018; 17(4):448-458. PubMed ID: 29099271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
    Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of MiR-122 Decreases Cerebral Ischemia-reperfusion Injury by Upregulating DJ-1-Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN)/Phosphonosinol-3 Kinase (PI3K)/AKT.
    Xue X; Wang H; Su J
    Med Sci Monit; 2020 Feb; 26():e915825. PubMed ID: 32061171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.
    Wang J; Guo J; Fan H
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5168-5175. PubMed ID: 31298410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
    Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑210‑3p regulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3.
    Jin Y; Wei J; Xu S; Guan F; Yin L; Zhu H
    Mol Med Rep; 2019 Jun; 19(6):4946-4954. PubMed ID: 30957179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of exosome-derived miR-21on chemotherapy resistance of esophageal cancer.
    Yang YC; Liu GJ; Yuan DF; Li CQ; Xue M; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1513-1519. PubMed ID: 30840273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
    Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-223 regulates CDDP resistance in pancreatic cancer via targeting FoxO3a.
    Huang R; Song X; Wang CM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7892-7898. PubMed ID: 31599414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
    Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
    Feng Y; Zou W; Hu C; Li G; Zhou S; He Y; Ma F; Deng C; Sun L
    Arch Biochem Biophys; 2017 Jun; 623-624():20-30. PubMed ID: 28495512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity.
    Su PF; Song SQ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6864-6872. PubMed ID: 30402851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
    Lin XM; Chen H; Zhan XL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.